MKI67 and neoplasm: Furthermore, the optimal way to incorporate criteria found to predict worse outcomes, including Ki-67 levels [72,73], tumor location in the pancreas [74,75], age > 45–50 years old [20,76], >50% tumor involvement of the liver [74], aberrant E-cadherin expression [73], and hepatomegaly [20] remains unclear.